피라졸론 유도체의 제조방법
    5.
    发明授权
    피라졸론 유도체의 제조방법 失效
    吡唑啉酮衍生物的制备方法

    公开(公告)号:KR1019900001080B1

    公开(公告)日:1990-02-26

    申请号:KR1019860008538

    申请日:1986-10-11

    Abstract: A process for prepg. pyrazolone dervis. of formula (I) comprises: (a) reacting halogen derivs. of formula (II) with primary amine of formula R4-NH2 in org. solvent(i.e. water, MeOH, EtOH) for 10 hr at 10-30 deg. C; (b) reacting with secondary haloketo cpd. in org. solvent i.e. benzene, toluene, dioxane in basic media i.e. NaHCO3, NaOH, triethylamine at 20-120 deg. C; and (c) reacting with hydrazine of formula R5NH-NH2 in org. solvent i.e. diethyleneglycole, THF in basic media i.e. KHCO3, NaOH. In the formulas, R1=isopropyl; R4=Me; R5=H or methanesulfonyl; X=Cl, Br or I. (I) are useful as an antipyretic analgesic.

    Abstract translation: 一个prepg的过程 吡唑啉酮衍生物 式(I)的化合物包括:(a)使卤素衍生物反应。 式(Ⅱ)化合物与式R 4 -NH 2的伯胺反应。 溶剂(即水,MeOH,EtOH)在10-30℃下搅拌10小时。 C; (b)与二级haloketo cpd反应。 在组织 溶剂,即苯,甲苯,二氧化硅在碱性介质,即NaHCO 3,NaOH,三乙胺中,在20-120度。 C; 和(c)与组分中式R5NH-NH2的肼反应。 溶剂即二乙二醇,在碱性介质中的THF,即KHCO 3,NaOH。 式中R1 =异丙基; R4 =甲基; R5 = H或甲磺酰基; X = Cl,Br或I.(I)可用作解热镇痛药。

Patent Agency Ranking